VENKATAPURAM G REDDY
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease VALLEY, AL NPI 1013943943
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease AL Novo Nordisk AS All categories
General Payments — all program years on this page
$2,395.74
- Category: General Payments
- Program years: PY2018–2024
- Record count: 75
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $154.20 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $154.20 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $44.59 | 2 |
| Lexicon Pharmaceuticals, Inc. | $44.46 | 2 |
| Kiniksa Pharmaceuticals International, plc | $26.58 | 1 |
| HEARTFLOW, INC. | $23.51 | 1 |
| Merck Sharp & Dohme Corporation | $15.06 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1081719036 | Lexicon Pharmaceuticals, Inc. | $21.45 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1081719038 | Lexicon Pharmaceuticals, Inc. | $23.01 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097204999 | Novo Nordisk Inc | $22.45 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097333705 | Novo Nordisk Inc | $22.14 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141868637 | Merck Sharp & Dohme LLC | $15.06 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154166230 | HEARTFLOW, INC. | $23.51 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154883377 | Kiniksa Pharmaceuticals International, plc | $26.58 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.